연구성과로 돌아가기
2022 연구자 정보 (28 / 1074)
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
| Author Name | 제1저자 여부 | 교신저자 여부 | Address | ResearcherID | ORCID | Paper Title | WoS Edition | 최상위 JCR(%) | WoS Category | Related Email |
|---|---|---|---|---|---|---|---|---|---|---|
|
Odeleye-Ajakaye, A. (Odeleye-Ajakaye, A) |
Merck & Co Inc, Kenilworth, NJ USA |
|
|
[JCR상위 1.9] Phase 2 study of pembrolizumab-based combination therapy in patients with microsatellite instability-high or mismatch repair-deficient stage IV colorectal cancer | SCIE | 1.9 | ONCOLOGY | |||
|
Oh, Yujin (Oh, Y) |
Korea Adv Inst Sci & Technol KAIST, Daejeon, South Korea Korea Adv Inst Sci & Technol, Dept Bio & Brain Engn, Daejeon, South Korea |
ABG-2034-2020 Oh, Yujin |
0000-0003-4319-8435 Oh, Yujin |
[JCR상위 1.9] Multi-task vision transformer using low-level chest X-ray feature corpus for COVID-19 diagnosis and severity quantification [JCR상위 7.5] Self-evolving vision transformer for chest X-ray diagnosis through knowledge distillation |
SCIE | 1.9 |
COMPUTER SCIENCE, ARTIFICIAL INTELLIGENCE;COMPUTER SCIENCE, INTERDISCIPLINARY APPLICATIONS;ENGINEERING, BIOMEDICAL;RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING MULTIDISCIPLINARY SCIENCES |
jong.ye@kaist.ac.kr; | ||
|
Park, Sangjoon (Park, S) |
제1저자 |
Korea Adv Inst Sci & Technol KAIST, Daejeon, South Korea Korea Adv Inst Sci & Technol, Dept Bio & Brain Engn, Daejeon, South Korea |
|
0000-0002-9223-3172 Park, Sangjoon |
[JCR상위 1.9] Multi-task vision transformer using low-level chest X-ray feature corpus for COVID-19 diagnosis and severity quantification [JCR상위 7.5] Self-evolving vision transformer for chest X-ray diagnosis through knowledge distillation |
SCIE | 1.9 |
COMPUTER SCIENCE, ARTIFICIAL INTELLIGENCE;COMPUTER SCIENCE, INTERDISCIPLINARY APPLICATIONS;ENGINEERING, BIOMEDICAL;RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING MULTIDISCIPLINARY SCIENCES |
jong.ye@kaist.ac.kr; | |
|
Popat, Sanjay (Popat, S) |
Royal Marsden Natl Hlth Serv Fdn Trust, Lung Unit, London, England Inst Canc Res, London, England Royal Marsden Natl Hlth Serv Fdn Trust, Lung Unit, London SW3 6JJ, England |
AAO-1634-2021 Popat, Sanjay |
|
[JCR상위 1.9] Sequential afatinib and osimertinib in Asians with EGFRm plus NSCLC: combined analysis of two non-interventional studies [JCR상위 34.5] Sequential Afatinib and Osimertinib in Asian Patients with EGFR Mutation-Positive Non-Small Cell Lung Cancer and Acquired T790M: Combined Analysis of Two Global Non-Interventional Studies |
SCIE | 1.9 |
ONCOLOGY BIOTECHNOLOGY & APPLIED MICROBIOLOGY;ONCOLOGY |
sanjay.popat@rmh.nhs.uk; | ||
|
Reig, M. (Reig, M) |
Barcelona Univ, Hosp Clin Barcelona, Barcelona Clin Liver Canc BCLC, Barcelona, Spain |
ABB-5414-2021 Reig, Maria |
|
[JCR상위 1.9] Outcomes by baseline liver function in patients with unresectable hepatocellular carcinoma treated with tremelimumab and durvalumab in the phase 3 HIMALAYA study | SCIE | 1.9 | ONCOLOGY | |||
|
Sendur, M. (Sendur, M) |
Ankara Yildirim Beyazit Univ, Fac Med, Ankara, Turkey Ankara City Hosp, Ankara, Turkey |
H-7555-2014 Sendur, Mehmet |
|
[JCR상위 1.9] Phase 2 study of pembrolizumab-based combination therapy in patients with microsatellite instability-high or mismatch repair-deficient stage IV colorectal cancer | SCIE | 1.9 | ONCOLOGY | |||
|
Seo, Joon Beom (Seo, JB) |
Univ Ulsan, Asan Med Ctr, Coll Med, Seoul, South Korea |
AAQ-5445-2021 Seo, Joon |
|
[JCR상위 1.9] Multi-task vision transformer using low-level chest X-ray feature corpus for COVID-19 diagnosis and severity quantification [JCR상위 7.5] Self-evolving vision transformer for chest X-ray diagnosis through knowledge distillation |
SCIE | 1.9 |
COMPUTER SCIENCE, ARTIFICIAL INTELLIGENCE;COMPUTER SCIENCE, INTERDISCIPLINARY APPLICATIONS;ENGINEERING, BIOMEDICAL;RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING MULTIDISCIPLINARY SCIENCES |
jong.ye@kaist.ac.kr; | ||
|
Sposetti, C. (Sposetti, C) |
Univ Milan, Fdn IRCCS Ist Nazl Tumori Milano, Milan, Italy |
LFT-4451-2024 Sposetti, Caterina |
0000-0003-3211-8516 Sposetti, Caterina |
[JCR상위 1.9] Phase 2 study of pembrolizumab-based combination therapy in patients with microsatellite instability-high or mismatch repair-deficient stage IV colorectal cancer | SCIE | 1.9 | ONCOLOGY | |||
|
Tak, W. (Tak, W) |
Kyungpook Natl Univ, Sch Med, Daegu, South Korea |
|
|
[JCR상위 1.9] Outcomes by baseline liver function in patients with unresectable hepatocellular carcinoma treated with tremelimumab and durvalumab in the phase 3 HIMALAYA study | SCIE | 1.9 | ONCOLOGY | |||
|
Tanasanvimon, S. (Tanasanvimon, S) |
Chulalongkorn Univ, King Chulalongkorn Mem Hosp, Fac Med, Bangkok, Thailand |
|
|
[JCR상위 1.9] Outcomes by baseline liver function in patients with unresectable hepatocellular carcinoma treated with tremelimumab and durvalumab in the phase 3 HIMALAYA study | SCIE | 1.9 | ONCOLOGY | |||
|
Varela, M. (Varela, M) |
Univ Oviedo, Hosp Univ Cent Asturias, Oviedo, Spain |
|
|
[JCR상위 1.9] Outcomes by baseline liver function in patients with unresectable hepatocellular carcinoma treated with tremelimumab and durvalumab in the phase 3 HIMALAYA study | SCIE | 1.9 | ONCOLOGY | |||
|
Vogel, A. (Vogel, A) |
제1저자 | Med Hsch, Hannover, Germany |
A-8437-2012 Vogel, Arndt |
|
[JCR상위 1.9] Outcomes by baseline liver function in patients with unresectable hepatocellular carcinoma treated with tremelimumab and durvalumab in the phase 3 HIMALAYA study | SCIE | 1.9 | ONCOLOGY | ||
|
Wyrwicz, L. (Wyrwicz, L) |
Maria Sklodowska Curie Natl Res Inst Oncol, Warsaw, Poland |
|
|
[JCR상위 1.9] Phase 2 study of pembrolizumab-based combination therapy in patients with microsatellite instability-high or mismatch repair-deficient stage IV colorectal cancer | SCIE | 1.9 | ONCOLOGY | |||
|
Yalcin, S. (Yalcin, S) |
Hacettepe Univ, Ankara, Turkey |
|
|
[JCR상위 1.9] Phase 2 study of pembrolizumab-based combination therapy in patients with microsatellite instability-high or mismatch repair-deficient stage IV colorectal cancer | SCIE | 1.9 | ONCOLOGY | |||
|
Yang, Cheng-Ta (Yang, CT) |
Chang Gung Mem Hosp, Dept Thorac Med, Taoyuan, Taiwan |
|
0000-0003-1846-1027 Yang, Cheng-Ta |
[JCR상위 1.9] Sequential afatinib and osimertinib in Asians with EGFRm plus NSCLC: combined analysis of two non-interventional studies [JCR상위 34.5] Sequential Afatinib and Osimertinib in Asian Patients with EGFR Mutation-Positive Non-Small Cell Lung Cancer and Acquired T790M: Combined Analysis of Two Global Non-Interventional Studies |
SCIE | 1.9 |
ONCOLOGY BIOTECHNOLOGY & APPLIED MICROBIOLOGY;ONCOLOGY |
sanjay.popat@rmh.nhs.uk; |
페이지 이동: